Led by Jane Linderbaum, MS, ARNP, FACC, FPCNA, this course takes a deep dive into caring for patients with hypertrophic cardiomyopathy (HCM). Hear from experts in the HCM field, including a patient living with HCM, on how to navigate novel treatments, the importance of team-based care and including the patient as a part of the team, and finally hear what is upcoming in the field.

This discussion is part of a four-part series on HCM. To view other sessions in the series visit:

Learning Objectives

  1. Review highlights of team-based care approach to ordering and administering novel HCM pharmaceutical therapy
  2. Using case-based scenarios, identify best practices for prescribing and administering novel medications for HCM
  3. Discuss how to maximize effective communications in team-based care
  4. Describe effective strategies for shared decision-making for patients with HCM and their family

Non-CE certificate of attendance/participation is available upon submission of the program evaluation.

Non-Member Price

$0

Member Price

$0

CE Contact Hours

0

Pharmacology CE Hours

0

Milind Desai

MD, MBA

Norma Flores

DNP, CRNP, AGACNP-BC, AACC, HF-Cert, CCRN

Jane A. Linderbaum

MS, ARNP, CNP, FACC, FPCNA

Matthew Martinez

MD, FACC

AANP-provider-logo

Accreditation:

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.